Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum- free medium and chemoradiotherapy

International Journal of Biological Sciences

Volumn 9, Issue 5, 2013, Pages 472-479

  Wang, Lei ^a   Huang, Xing ^b   Zheng, Xinmin ^a   Wang, Xinghuan ^a   Li, Shiwen ^a   Zhang, Lin ^a   Yang, Zhonghua ^a   Xia, Zhiping ^a  

^a WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF ARTS AND SCIENCE   (China)

Author keywords

Cancer stem cells; Chemotherapy; Prostate cancer; Radiotherapy; Serum free medium culture

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; DOCETAXEL; GLYCOPROTEIN; HERMES ANTIGEN; LEUKOCYTE ANTIGEN; PEPTIDE; TAXOID;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER STEM CELL; CHEMORADIOTHERAPY; CHEMOTHERAPY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; PROSTATE CANCER; PROSTATE TUMOR; RADIATION EXPOSURE; RADIOTHERAPY.; SERUM-FREE MEDIUM CULTURE;

CANCER STEM CELLS; CHEMOTHERAPY; PROSTATE CANCER; RADIOTHERAPY.; SERUM-FREE MEDIUM CULTURE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CHEMORADIOTHERAPY; CULTURE MEDIA, SERUM-FREE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; PEPTIDES; PROSTATIC NEOPLASMS; TAXOIDS; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 84879301722     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5855     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
3. Grubb RL 3rd, Kibel AS. Prostate cancer: screening, diagnosis and management in 2007. Mo Med.2007; 104: 408-413.
4. Sagar J, Chaib B, Sales K, et al. Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int. 2007; 7: 9.
5. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414: 105-111.
6. Giordano A, Fucito A, Romano G, et al. Carcinogenesis and environment: the cancer stem cell hypothesis and implications for the development of novel therapeutics and diagnostics. Front Biosci. 2007; 12: 3475-3482.
7. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 2009; 69: 1302-1313.
8. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004; 64: 7011-7021.
9. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121: 823-835.
10. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005; 65: 10946-10951.
11. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005; 5: 275-284.
12. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008; 8: 545-554.
13. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444: 756-760.
14. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006; 66: 9339-9344.
15. Richardson GD, Robson CN, Lang SH, et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci. 2004; 117: 3539-3545.
16. Wei C, Guomin W, Yujun L, et al. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol Ther. 2007; 6: 763-768.
17. Miki J, Furusato B, Li H, et al. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 2007; 67: 3153-3161.
18. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006; 25: 1696-1708.
19. Maitland NJ, Collins AT. Prostate cancer stem cells: a new target for therapy. J Clin Oncol. 2008; 26: 2862-2870.
20. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumor initiating cells. Nature. 2004; 432: 396-401.
21. Dey D, Saxena M, Paranjape AN, et al. Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One. 2009; 4: e5329.
22. Zhang L, Jiao M, Li L, et al. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties. J Cancer Res Clin Oncol. 2012; 138: 675-686.
23. Lang SH, Frame FM, Collins AT. Prostate cancer stem cells. J Pathol. 2009; 217: 299-306.
24. Ma S, Lee TK, Zheng BJ, et al. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene. 2008; 27: 1749-1758.
25. Pfeiffer MJ, Schalken JA. Stem cell characteristics in prostate cancer cell lines. Eur Urol. 2010; 57: 246-255.
26. Rajasekhar VK, Studer L, Gerald W, et al. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun. 2011; 2: 162.
27. Vander Griend DJ, Karthaus WL, Dalrymple S, et al. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res. 2008; 68: 9703-9711.
28. Du Z, Qin R, Wei C, et al. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells. Dig Dis Sci. 2011; 56: 741-750.